Themis Medicare Ltd.
| BSE: 530199 | Sector: Health care |
| NSE: THEMISMED | ISIN Code: INE083B01016 |
| BSE 00:00 | 12 Aug | 800.00 |
-1.00 (-0.12%) |
OPEN
810.65 |
HIGH
810.65 |
LOW
800.00 |
| NSE 00:00 | 12 Aug | 799.90 |
-3.60 (-0.45%) |
OPEN
818.60 |
HIGH
818.60 |
LOW
798.00 |
| OPEN | 810.65 |
| PREVIOUS CLOSE | 801.00 |
| VOLUME | 69 |
| 52-Week high | 1198.80 |
| 52-Week low | 692.00 |
| P/E | 15.84 |
| Mkt Cap.(Rs cr) | 736 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Themis Medicare Ltd. (THEMISMED) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Cipla | 1027.35 | -11.05 | -1.06 | 2957.93 |
| Divi's Lab. | 3728.20 | -219.60 | -5.56 | 2948.54 |
| Glaxosmi. Pharma | 1441.95 | -0.35 | -0.02 | 1690.53 |
| Glenmark Pharma. | 389.00 | 0.10 | 0.03 | 1649.45 |
| Dr Reddy's Labs | 4262.25 | 5.10 | 0.12 | 1623.20 |
| Alkem Lab | 2959.90 | -14.50 | -0.49 | 1541.25 |
| Aurobindo Pharma | 593.30 | 17.85 | 3.10 | 1454.71 |
| Gland Pharma | 2363.30 | 15.65 | 0.67 | 1212.16 |
| Alembic Pharma | 652.55 | 2.10 | 0.32 | 1175.39 |
| Torrent Pharma. | 1539.20 | 3.95 | 0.26 | 991.45 |
| Sanofi India | 6382.90 | -24.20 | -0.38 | 944.40 |
| Ipca Labs. | 928.00 | -87.50 | -8.62 | 870.94 |
| Zydus Lifesci. | 386.90 | 5.15 | 1.35 | 857.90 |
| Abbott India | 18761.95 | -180.00 | -0.95 | 798.70 |
| Laurus Labs | 565.75 | 0.70 | 0.12 | 750.09 |
| Ajanta Pharma | 1276.30 | 5.50 | 0.43 | 719.86 |
| Apollo Hospitals | 4309.85 | -124.40 | -2.81 | 665.20 |
| Pfizer | 4219.35 | 17.70 | 0.42 | 612.56 |
| Piramal Enterp. | 1919.95 | 13.70 | 0.72 | 572.28 |
| Suven Pharma | 454.25 | 3.75 | 0.83 | 558.10 |
Quick Links for Themis Medicare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
